Specian

Pharmaceutical products and marketing services in healthcare sectors across India.

About Specian

Specian is an Agriculture company. Pharmaceutical products and marketing services in healthcare sectors across India. It operates in the Agriculture and Healthcare sectors. Its Indian entity Specian Healthcare Private Limited reported revenue of β‚Ή2.10 Cr. Specian offers products and services including Diabeto and Cardio. Its focus areas include Research and Development, Biotech Innovations, R&D Services and Pharmaceuticals.

Company details

Specian Healthcare Private Limited is recognized as one of Indias emerging pharmaceutical companies that is equipped with world-class manufacturing units and research and development facilities spread across the country. Marketing efforts are conducted through experienced personnel, focusing on innovative products in areas such as Diabeto, Cardio, and Gastro to enhance public health. The company is backed by advanced technology and partnerships, ensuring that lives are improved through reliable and modern pharmaceutical solutions. Overall, operations are designed to support nationwide distribution and innovation in the healthcare sector.

  • Sectors
    Agriculture
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website specian.co.in
  • Legal Name Specian Healthcare Private Limited
  • Date of Incorporation 26 Mar, 2018
  • Jurisdiction Gmc, Assam, India
Key Metrics
  • Indian entity revenue
    ₹2.10 Cr

    FY 2024 · +104% YoY

  • Indian entity net profit
    ₹5.8 Lakh

    FY 2024 · 3% margin

  • Indian entity EBITDA
    ₹9 Lakh

    FY 2024 · 4% margin

Products & Services of Specian

Specian offers a comprehensive portfolio of products and services, including Diabeto and Cardio.

Diabeto
Pharmaceuticals

Medicines for diabetes management are provided as part of the company's innovative offerings.

Cardio
Pharmaceuticals

Products for cardiovascular health are offered to address related medical needs.

Board of directors of Specian Healthcare Private Limited (Specian)

Specian Healthcare Private Limited is the primary company behind Specian. The board of Specian Healthcare Private Limited currently have 4 directors; the longest-serving is Rumi Dey, appointed in 2018. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rumi Dey
DIN 08159250
Director18 Jun 20188 yrs 5 moSpecian Healthcare Private Limited
Bijoya Saha
DIN 08721354
Director12 Sep 20206 yrs 2 moSpecian Healthcare Private Limited
Suchismita Bhattacharjee
DIN 07095398
Director01 Jan 20242 yrs 10 moSpecian Healthcare Private Limited
Dolly Kakati Das
DIN 10776933
Director11 Aug 20251 yr 3 moSpecian Healthcare Private Limited

Financials of Specian

Figures of Specian Healthcare Private Limited, the primary company behind Specian, for FY 2024. Revenue was ₹2.10 Cr (+104% year on year). Net profit was ₹5.8 Lakh (3% margin). EBITDA was ₹9 Lakh (4% margin). Revenue has grown at a compounded annual rate of +2279% over three years.

  • ₹2.10 CrRevenue · FY 2024 · +104% YoY
  • ₹5.8 LakhNet profit · 3% margin
  • ₹9 LakhEBITDA · 4% margin
  • ₹25 LakhPaid-up capital
  • 16Employees (provident fund records)
  • +2279%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Specian Healthcare Private Limited are on its company page.

Premium access

Detailed financial statements for Specian

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Specian

The primary company behind Specian, Specian Healthcare Private Limited, reported revenue of β‚Ή2.10 Cr for FY 2024, up 104% year on year.

Specian Healthcare Private Limited is recognized as one of Indias emerging pharmaceutical companies that is equipped with world-class manufacturing units and research and development facilities spread across the country. Marketing efforts are conducted through experienced personnel, focusing on innovative products in areas such as Diabeto, Cardio, and Gastro to enhance public health. The company is backed by advanced technology and partnerships, ensuring that lives are improved through reliable and modern pharmaceutical solutions. Overall, operations are designed to support nationwide distribution and innovation in the healthcare sector.

Specian offers Diabeto and Cardio.

Specian operates through Specian Healthcare Private Limited.

The legal entities of Specian currently have 4 directors, including Bijoya Saha, Suchismita Bhattacharjee, Rumi Dey and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available